Trevi Therapeutics (TRVI) News
NASDAQ: TRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.19+0.365 (+2.85%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
TRVI news summary
We found 1 recent headline mentioning Trevi Therapeutics (TRVI): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, TRVI is up 2.85% at $13.19. The most recent story, "After Hours Most Active for Oct 9, 2026 : FTXR, NVDA, BKD, GRAB, TRVI, URGN, INDV, LUV, WFC, ESI, OSG, BAC", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology